INVESTORS Events Details Global Hepatitis Summit 2023 Presentation - A gene editing approach for chronic hepatitis B: Elimination of hepatitis B virus in vivo by targeting cccDNA and integrated viral genomes with a sequence-specific ARCUS nuclease Apr 26, 2023 at 8:30 AM CEST Supporting Materials View Presentation 2.4 MB Investors Events & Presentations Press Releases Corporate Deck Stock Information Analyst Coverage SEC Filings Corporate Governance Sustainability Investor FAQs Investor Tools Print Page Email Alerts Contact IR RSS Feeds
Global Hepatitis Summit 2023 Presentation - A gene editing approach for chronic hepatitis B: Elimination of hepatitis B virus in vivo by targeting cccDNA and integrated viral genomes with a sequence-specific ARCUS nuclease Apr 26, 2023 at 8:30 AM CEST Supporting Materials View Presentation 2.4 MB
